Skip to main content
Signal8

Shiferman Gregory L.

SEC insider (Form 3/4/5 filer). CIK 0002041689. SVP and General Counsel at Voyager Therapeutics, Inc. (VYGR) and 1 other issuer. 14 reported Form 4/5 transactions since Sep 2024; latest on Apr 1, 2026. Located in LEXINGTON, MA.

Companies Shiferman Gregory L. has filed insider reports for

  • Voyager Therapeutics, Inc. (VYGR): Officer, SVP and General Counsel
  • Sage Therapeutics, Inc. (SAGE): Officer, See Remarks
Shiferman Gregory L. profile photo

Shiferman Gregory L.

CIK: 0002041689

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)5 (35.7%)

Compensation grants

Other (G, F, J, C, D, …)9 (64.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

Voyager Therapeutics, Inc. logo
VYGR

Voyager Therapeutics, Inc.

Officer
Sage Therapeutics, Inc. logo
SAGE

Sage Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (14 total)

  • Voyager Therapeutics, Inc. logo
    VYGR

    Voyager Therapeutics, Inc.

    Apr 1, 2026
    Award
    Direct
    50K shares-
  • Voyager Therapeutics, Inc. logo
    VYGR

    Voyager Therapeutics, Inc.

    Jan 6, 2026
    Award

    Stock Option (Right to Buy)

    Direct
    100K shares-
  • Sage Therapeutics, Inc. logo
    SAGE

    Sage Therapeutics, Inc.

    Jul 31, 2025
    Disposition
    Direct
    23.7K shares-
  • Sage Therapeutics, Inc. logo
    SAGE

    Sage Therapeutics, Inc.

    Jul 31, 2025
    Tender Offer
    Direct
    7.2K shares-
  • Sage Therapeutics, Inc. logo
    SAGE

    Sage Therapeutics, Inc.

    Jun 24, 2025
    Tax Payment
    Direct
    79 shares at avg. $9.22$728.38
  • Sage Therapeutics, Inc. logo
    SAGE

    Sage Therapeutics, Inc.

    Apr 10, 2025
    Award
    Direct
    525 shares-
  • Sage Therapeutics, Inc. logo
    SAGE

    Sage Therapeutics, Inc.

    Apr 10, 2025
    Tax Payment
    Direct
    176 shares at avg. $6.91$1K
  • Sage Therapeutics, Inc. logo
    SAGE

    Sage Therapeutics, Inc.

    Mar 24, 2025
    Tax Payment
    Direct
    79 shares at avg. $8.21$648.59
  • Sage Therapeutics, Inc. logo
    SAGE

    Sage Therapeutics, Inc.

    Feb 24, 2025
    Tax Payment
    Direct
    2.5K shares at avg. $7.49$19K
  • Sage Therapeutics, Inc. logo
    SAGE

    Sage Therapeutics, Inc.

    Feb 13, 2025
    Tax Payment
    Direct
    251 shares at avg. $7.18$2K

1-10 of 14